Clinical trials
Phase 4 Myocardial Infarction trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III | 2 |
| AstraZeneca | 1 |
| Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec | 1 |
| Eli Lilly and Company | 1 |
| Fundación para la Investigación del Hospital Clínico de Valencia | 1 |
| GRACIA Group | 1 |
| Hospital Juan Canalejo | 1 |
| Hospital Virgen de la Salud | 1 |
| Institut d'Investigació Biomèdica de Bellvitge | 1 |
| Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myocardial Infarction | 15 |
| Stroke | 3 |
| Acute Coronary Syndrome | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Hemorrhage | 2 |
| Angina Pectoris | 1 |
| Aortic Valve Disease | 1 |
| Cardiovascular Diseases | 1 |
| Diabetes Mellitus | 1 |
| Frailty | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.